What Testosterone Research Still Does Not Know

Testosterone gets talked about as if it is a simple knob you can turn up or down, and in my experience that is where a lot of confusion begins. People want clean answers because the symptoms linked to testosterone feel personal. Libido, energy, confidence, strength, mood, body composition, and a sense of being yourself all sit close to identity. When something feels off, it is tempting to look for one hormone that explains everything. Testosterone becomes that hormone, and the internet makes it seem like research has settled the details.

I did some digging and what I found is that testosterone science is strong in some areas and surprisingly uncertain in others. We know a great deal about how testosterone is made, how it circulates, and what happens when levels are truly very low or very high. We also have decent evidence for specific treatments in specific groups. But there are still gaps, and some of them matter in real life. They affect how we interpret blood tests, how we define deficiency, how we weigh risks and benefits of treatment, and how we talk to people who feel unwell but do not fit into neat categories.

This topic matters because uncertainty can easily be exploited. It can be exploited by supplement companies selling certainty in a bottle. It can be exploited by clinics promising transformations that sound medical but are actually marketing. It can also be exploited by fear based messaging that makes people think testosterone therapy is automatically dangerous. In my opinion, the healthiest approach is calm honesty. Science does not need to be perfect to be useful, but we do need to know where the edges of certainty are.

In this article, I will explain what testosterone research still does not know, in a reassuring, evidence based, UK style. I will cover what it is, what the challenge was, why certain questions were believed impossible to answer, the physical systems under stress when testosterone is out of balance, the mental strategies that shape how people interpret uncertainty, and what long term damage or recovery can look like. I will also share what I have found when looking at how trusted UK health sources typically frame testosterone, and I will keep the language clear and human.

What It Is

Testosterone is a steroid hormone produced mainly in the testes in men and in smaller amounts in the ovaries and adrenal glands in women, with adrenal contributions in everyone. It influences sexual development and function, muscle and bone maintenance, red blood cell production, and aspects of mood and motivation. Testosterone also converts into other hormones, including oestradiol, which plays important roles in bone and brain health in both men and women.

Testosterone research is the body of scientific work that tries to understand how testosterone works in the body, how to measure it, what happens when it is low or high, and how to treat problems safely. Some of that research is basic biology. Some is clinical research in real people. Some is public health research looking at patterns across populations. The gaps in knowledge tend to appear where biology meets real life complexity, such as how symptoms map to levels, how ageing changes the picture, and how treatments affect long term outcomes.

When I say what research still does not know, I am not saying scientists are clueless. I am saying there are specific areas where the evidence is mixed, incomplete, or difficult to apply to an individual person sitting in front of a clinician saying, I feel exhausted and I do not feel like myself.

What The Challenge Was

The challenge with testosterone research is that testosterone is not a single simple signal. It is part of a system, and systems are messy. Testosterone levels vary by time of day, sleep quality, illness, stress, body composition, and medication. Testosterone also interacts with other hormones and with binding proteins in the blood. Different tissues respond differently. Some people feel symptoms strongly at levels that look normal. Others feel fine at levels that look low. That variability makes it hard to draw sharp lines.

I did some investigating and discovered that many of the big unanswered questions come from practical limitations in research design. It is hard to run long term randomised trials that follow people for many years. It is hard to standardise lifestyle factors like sleep and stress. It is hard to measure outcomes like wellbeing and libido with perfect objectivity. It is also hard to separate the effects of testosterone from the effects of whatever caused testosterone to be low in the first place, such as obesity, chronic illness, or sleep apnoea.

Another challenge is that testosterone is culturally loaded. People want it to mean something about vitality and masculinity. That cultural weight can distort how research is interpreted. If a study finds a modest average benefit, it can be marketed as a life changing effect. If a study finds a potential risk in a particular group, it can be amplified into a universal warning. In my experience, the science often gets pulled into narratives that are not actually about science.

There is also the challenge of clinical thresholds. Healthcare systems often need categories. Eligible or not eligible. Deficient or not deficient. Yet biology is continuous. People fall in the grey zone, and research does not always tell us what to do with grey zones.

Why It Was Believed Impossible

Some questions about testosterone were believed impossible because the outcomes we care about are long term and multi factor. For example, does testosterone therapy change the risk of heart disease over decades. Does it change the risk of dementia. Does it change overall mortality. These are huge questions influenced by sleep, diet, smoking, exercise, genetics, and socioeconomic factors. Trying to isolate the effect of testosterone is like trying to isolate the effect of one instrument in an orchestra when the whole symphony is changing.

I did some digging and what I found is that some questions are also hard because of ethics. You cannot ethically randomise people to unsafe extremes for years. You cannot randomise people to remain deficient if they are severely symptomatic and need treatment. That means some evidence comes from observational studies, which are useful but can be confounded.

It can also feel impossible because testosterone is not just a male hormone. It exists in everyone, and it behaves differently across sexes and across life stages. Much of the historical research focus has been on men, especially older men, which leaves gaps in understanding for women and for younger populations.

In my experience, the way through this is not to give up. It is to accept uncertainty as part of evidence based care, and to make decisions using the best available evidence plus individual context.

What Research Still Does Not Know About Symptoms and Testosterone Levels

One of the biggest unanswered questions, and one that affects real people daily, is how well testosterone levels predict symptoms.

I did some investigating and discovered that symptoms commonly attributed to low testosterone, such as fatigue, low mood, reduced motivation, and reduced exercise performance, are extremely non specific. They overlap with sleep deprivation, depression, anxiety, thyroid problems, iron deficiency, diabetes, chronic pain, and burnout. Libido and erectile function are more specifically linked to androgens, but even those are influenced by relationship factors, stress, cardiovascular health, and mental health.

Research has not fully solved the question of why one man with a modestly low level feels terrible while another with a similar level feels fine. Some possible explanations include differences in androgen receptor sensitivity, differences in binding proteins, differences in oestradiol conversion, differences in sleep quality, and differences in inflammation. But these are not routinely measured in clinical practice, and the evidence does not yet allow easy personalised prediction.

Another uncertain area is the role of free testosterone versus total testosterone. Total testosterone measures the total amount in the blood. Free testosterone estimates what is not bound to proteins and is more available to tissues. Research suggests free testosterone can matter, especially when binding proteins vary, but measuring it accurately is not always straightforward and methods differ. This creates uncertainty in interpretation. Two people can have the same total testosterone but different free testosterone, and symptoms might align differently. Research still debates the best practical measurement approach in everyday healthcare.

From what I gather, the honest clinical reality is that testosterone levels are a piece of the puzzle, not the whole picture. Research has not provided a simple symptom to level conversion chart, and that is why grey zones exist.

What Research Still Does Not Know About What Counts as Low

People often ask, what is a normal testosterone level. They expect one number. In my experience, the truth is more complicated.

Reference ranges are created from populations, and populations include people with different health states. If a population has high rates of obesity and poor sleep, the range might shift lower than what might be considered optimal for wellbeing. This raises an uncomfortable research question. Are our reference ranges reflecting healthy physiology or simply reflecting the average of a modern population under stress. Research discusses this, but there is no universal answer.

There is also uncertainty about age related decline. Testosterone tends to decline gradually with age in many men, but how much of that decline is inevitable ageing and how much is modifiable through lifestyle is still debated. If a man’s testosterone is lower at sixty than at thirty, is that normal ageing, or is that a sign of modifiable metabolic strain. Research suggests body composition, sleep, and illness account for a meaningful portion, but not all, of the change.

I did some digging and what I found is that there is also debate about the cut off for treatment in men with borderline levels. Some guidelines prefer clear low levels plus symptoms. Others allow treatment trials in carefully selected men with significant symptoms and repeated low to borderline levels, especially if other causes have been addressed. Research does not provide absolute certainty because trials vary in design and outcomes.

For women, the uncertainty can be even greater because testosterone levels are much lower and reference ranges are narrower and less well standardised. Symptoms attributed to low testosterone in women can overlap with menopause transition, stress, thyroid issues, and other endocrine factors. Research is still developing in this area, and clinical practice is more cautious and specialist.

What Research Still Does Not Know About Testosterone and Mental Health

This is one of the most emotionally important areas, and also one of the most complex.

I did some investigating and discovered that testosterone and mood have a two way relationship. Low testosterone in men can be associated with low mood, irritability, and reduced motivation. But depression and chronic stress can also lower testosterone. That means it is not always clear what is cause and what is consequence. Treating testosterone might improve mood in some men who are truly deficient. But in men whose mood issues are driven primarily by depression, trauma, or chronic stress, testosterone therapy may have limited effect.

Research still does not fully predict who will experience mood improvement with testosterone therapy. Some trials show modest average improvements in depressive symptoms in certain groups, but results are mixed. One reason is that depression is not one thing. It has many pathways. Testosterone might help in some pathways and not others.

Another uncertain area is anxiety and irritability. Some people fear that testosterone therapy will make them aggressive. In my experience, excessive dosing and unstable levels can worsen irritability in some people, while restoring deficient levels can improve emotional stability. Research suggests the dose and baseline context matter, but the public narrative is often too simplistic.

There is also an unresolved question about cognition. People sometimes claim testosterone improves focus and memory. Research has not provided consistent proof of a significant cognitive enhancement effect in the general population. It may support wellbeing and energy, which can indirectly support cognition, but direct brain effects are hard to separate from those indirect effects. This area is still evolving.

What Research Still Does Not Know About Cardiovascular Risk

This is probably the most debated topic in testosterone medicine, and it is a good example of why simple headlines fail.

Testosterone influences red blood cell production, fluid balance, fat distribution, insulin sensitivity, and lipid profiles. These factors can affect cardiovascular risk. But the direction of effect depends on baseline health, dosing, monitoring, and whether testosterone deficiency itself is a marker of poor health.

I did some digging and what I found is that some studies suggest testosterone deficiency is associated with higher cardiovascular risk, but that does not prove deficiency causes the risk. It could be that poor health lowers testosterone. When it comes to testosterone therapy, some studies suggest potential risks in certain contexts, while others suggest neutral or even beneficial effects when therapy is appropriately prescribed and monitored. The evidence is not uniform.

One reason research is still uncertain is that cardiovascular outcomes take years to emerge. Trials are often shorter. Observational studies can be confounded because men who receive testosterone therapy may differ in important ways from those who do not. They may have different healthcare access, different baseline risk factors, and different monitoring.

In my experience, the most evidence based approach is pragmatic. Cardiovascular risk should be assessed in every man considering therapy. Blood pressure, sleep apnoea risk, diabetes risk, smoking, and cholesterol matter. Testosterone therapy should never be treated as a substitute for cardiovascular health management. Research has not eliminated uncertainty, so careful monitoring and risk factor management are essential.

What Research Still Does Not Know About Prostate Health

This is another area full of public fear and outdated assumptions.

Historically, there was a strong belief that testosterone therapy could fuel prostate cancer. Modern understanding is more nuanced. Prostate tissue is androgen sensitive, and testosterone plays a role in prostate physiology, but the relationship between testosterone levels and prostate cancer risk is complex. Research has not produced a simple rule that higher testosterone equals higher cancer risk across all contexts.

I did some investigating and discovered that the clinical approach tends to be cautious monitoring rather than panic. Prostate related markers and urinary symptoms are reviewed as appropriate based on age and risk. The uncertainty here is not a reason to avoid treatment in men who need it, but it is a reason for proper assessment and monitoring.

Research still does not fully answer long term questions in all risk groups, particularly older men with multiple risk factors, because long term randomised trials are difficult. That is why clinical practice often relies on careful screening, shared decision making, and monitoring rather than claiming complete certainty.

What Research Still Does Not Know About Fertility and Recovery After Stopping Therapy

A huge practical question for many men is what happens to fertility and natural production if they start testosterone therapy and later stop.

It is well established that external testosterone can suppress sperm production by reducing the brain signals that stimulate the testes. But research still cannot perfectly predict how quickly sperm production will recover after stopping, or whether it will fully recover in every man. Recovery varies with duration of use, baseline fertility, age, and individual physiology.

I did some digging and what I found is that some men recover relatively smoothly, while others take longer, and some may need specialist support. That uncertainty is one reason fertility planning is such an important part of the decision before starting therapy. In my opinion, this is where research gaps matter in a very real way. A man might start therapy in his thirties, feel better, then decide later he wants children and find fertility recovery is more complicated than he expected.

There is also uncertainty about recovery of natural testosterone production after stopping therapy. If a man had functional low testosterone due to obesity or stress, and he improves those factors, natural production may recover more fully. If a man had primary testicular failure, it may not. Research supports these broad patterns, but individual prediction remains uncertain.

What Research Still Does Not Know About Testosterone and Ageing

Testosterone is often talked about as an anti ageing hormone, and this is where I think research gets misused.

Ageing involves many systems. Testosterone declines gradually for many men, but it is not the only driver of ageing changes. Muscle loss, reduced activity, increased inflammation, sleep changes, and metabolic shifts all contribute. Testosterone might influence some of these, but research has not proven that testosterone therapy is a general anti ageing intervention for men with normal levels.

I did some investigating and discovered that research tends to support therapy for men with confirmed deficiency and symptoms, not for broad lifestyle enhancement in men with normal levels. In men with deficiency, improving testosterone can improve quality of life and some physical outcomes such as muscle maintenance and bone health. But the evidence for using testosterone purely to slow ageing in otherwise healthy men is not definitive and carries risk.

Another uncertainty is what role testosterone plays in frailty. Frailty is influenced by muscle, bone, balance, cognition, and overall resilience. Testosterone might support muscle and bone, but frailty is multi factor. Research is still working out where testosterone fits in a wider frailty prevention strategy.

In my experience, the best anti ageing strategies are still the unglamorous ones, strength training, adequate protein, sleep, social connection, and management of chronic disease risk factors. Testosterone therapy is sometimes part of that, but only when deficiency is real.

What Research Still Does Not Know About Individual Differences

This is the area I find most fascinating, because it explains why people have such different experiences.

Some people respond strongly to modest hormonal changes. Others barely notice. Research is still exploring why. Possible factors include androgen receptor genetics, differences in receptor density, differences in tissue sensitivity, differences in inflammation, and differences in conversion to other hormones such as oestradiol and dihydrotestosterone.

I did some digging and what I found is that while genetic differences are real, they are not routinely tested in clinical practice because the evidence does not yet translate into clear treatment decisions. The science is not yet at the point where you can do a simple test and get a personalised testosterone plan with guaranteed results. That gap is important because personalised marketing often pretends the science is already there.

Another layer is the role of sex hormone binding globulin, the protein that binds testosterone in the blood. Levels of this protein vary with age, thyroid status, liver health, and other factors. This changes free testosterone. Research supports its importance, but everyday testing and interpretation still vary.

There is also uncertainty about what outcomes matter most. Some men want libido back. Some want energy. Some want strength. Some want mood stability. Research often measures broad outcomes, but individual priorities differ. This makes one size interpretations difficult.

The Physical Systems Under Stress

When testosterone is genuinely low, or when the testosterone system is unstable, several physical systems can be affected, and understanding these systems helps make sense of why the research questions are complex.

The Hypothalamus and Pituitary System

The brain controls testosterone production through signalling hormones. Stress, under eating, sleep disruption, and illness can reduce signalling. This is why functional low testosterone happens. Research still does not fully map the thresholds at which different stressors cause downshifts, because stressors vary and human lives vary.

Metabolic and Inflammatory Systems

Obesity, especially abdominal fat, is linked to inflammation and insulin resistance. These can suppress testosterone signalling. Weight loss can improve testosterone in many men, but the degree of improvement varies. Research continues to explore which men benefit most and what level of weight loss matters.

Sleep System

Sleep is deeply tied to testosterone rhythms. Sleep deprivation lowers testosterone, and sleep apnoea can contribute to low testosterone and fatigue. Research supports this link, but it is still not fully clear how much treating sleep apnoea alone can restore testosterone in different groups. In practice, many men feel better when sleep improves, regardless of testosterone changes.

Muscle and Bone Systems

Testosterone supports muscle maintenance and contributes to bone health through conversion to oestradiol. Research supports that severe deficiency can contribute to reduced bone density and muscle loss, but the extent to which mild deficiency affects these systems varies, and how much therapy restores long term outcomes in different age groups is still being studied.

Cardiovascular System

Testosterone influences red blood cells and can affect blood pressure and other factors. The uncertainty about long term cardiovascular effects is partly because this system is influenced by so many confounders.

Mental Strategies Involved

How people think about testosterone strongly shapes how they interpret research uncertainty.

The Desire for Certainty

When you feel unwell, uncertainty is uncomfortable. People want a yes or no answer, and they want a fix. In my experience, this drives people towards oversimplified messaging. If a clinic offers certainty, people feel relief, even if the certainty is not evidence based.

The Upgrade Narrative

Testosterone is often marketed as a lifestyle upgrade. This narrative interprets any uncertainty as permission to experiment. In my opinion, this is risky because testosterone therapy has real physiological consequences, including fertility suppression and changes in blood markers.

The Fear Narrative

Some people interpret uncertainty as danger. They avoid assessment and treatment even when they might benefit. They live with symptoms because they fear risk. This is also unhelpful. Uncertainty should lead to monitoring and shared decision making, not avoidance.

Confirmation Bias

People tend to notice evidence that supports what they already believe. Someone who wants testosterone therapy will notice studies that suggest benefit and ignore studies that show mixed results. Someone who fears it will notice risk signals and ignore benefit evidence. In my experience, the healthiest approach is to accept that both can be true in different contexts.

Identity and Shame

Testosterone is tied to identity. Men may feel ashamed if they have low testosterone. Others may feel proud if they are using therapy. Both emotions can distort decision making. Research uncertainty is best navigated with a calm, health focused mindset rather than with identity driven thinking.

Long Term Damage or Recovery

Research gaps matter most when people make decisions that affect long term health.

Long term damage can occur if people self medicate or use underground testosterone without proper diagnosis and monitoring. Risks include fertility suppression, elevated red blood cell levels, cardiovascular strain, mood instability, and delayed diagnosis of underlying issues such as sleep apnoea or depression.

Long term damage can also occur from untreated genuine deficiency. If testosterone is very low for a long time, there can be risks to bone density, muscle maintenance, sexual function, and wellbeing. The exact long term outcomes vary by individual, but severe deficiency is not something to ignore.

Recovery is possible in many cases, particularly when low testosterone is functional and linked to reversible factors such as obesity, sleep disruption, and chronic stress. Weight loss, improved sleep, treatment of sleep apnoea, reduced alcohol intake, and smarter training can improve testosterone levels and symptoms in many men. In cases of permanent hypogonadism, medical therapy can restore levels and improve quality of life, but it requires monitoring and ongoing review.

I did some digging and what I found is that the most reliable recovery path is the one that respects uncertainty. Instead of chasing certainty through extremes, use careful assessment, address foundations, and make gradual adjustments.

What This Means for Real People Making Decisions

If you are reading this because you feel that your testosterone might be low, the first thing I want to say is that your symptoms matter. Fatigue and low libido and low mood are not trivial. The second thing I want to say, based on what I have researched and what I gather from clinical framing, is that the safest path is rarely a shortcut.

Proper assessment matters because symptoms overlap with many conditions. Morning testing matters because testosterone fluctuates. Repeat testing matters because one test can mislead. Broader assessment matters because sleep, thyroid function, iron status, depression, diabetes risk, and medication effects can all mimic low testosterone symptoms.

Lifestyle factors matter because they can both lower testosterone and create symptoms that feel like low testosterone. Sleep and weight and alcohol and stress are not just background issues. They are often central.

Treatment decisions should be made with attention to fertility, because external testosterone can suppress sperm production. That is not a minor side effect. It is a life planning issue.

Monitoring matters because testosterone therapy can affect red blood cell levels and other safety markers, and monitoring helps keep treatment in the safe zone.

From what I gather, good care is patient and structured. It does not promise miracles. It aims for steady improvement and safety.

A Unique Closing Perspective on Living Well With Uncertainty

I did some digging and what I found is that the biggest risk in testosterone culture is not that science is uncertain. Science is always uncertain at the edges. The biggest risk is how people respond to that uncertainty. Some people fill the gap with myths and spend money chasing answers that do not exist. Some people fill the gap with fear and avoid care they might genuinely benefit from. Both responses are understandable, but neither is ideal.

In my experience, the best response is calmer and more human. Accept that testosterone is part of a complex system. Accept that symptoms can be real even when a single number is not dramatically abnormal. Accept that lifestyle can suppress hormones and that improving lifestyle can restore them. Accept that medical therapy can be valuable when deficiency is real, and that it requires monitoring and clear goals.

From what I gather, the most empowering thing you can do is shift your focus from certainty to clarity. Clarify what you are feeling. Clarify what your sleep and stress and diet look like. Clarify your fertility plans. Clarify your test results with proper timing and repeat checks. Clarify your risk factors. Then make decisions that are steady and safe.

In my opinion, testosterone research will continue to evolve, and some of today’s grey areas will become clearer. But you do not need perfect science to make good choices right now. You need a respectful relationship with your body, a willingness to address the basics, and a medical approach that treats you as a whole person rather than as a single hormone value. That combination tends to bring the best outcome, not just higher numbers, but better wellbeing, better resilience, and a sense that your health is being managed with care rather than with hype.